Aarti Pharmalabs Limited (AARTIPHARM.NS)
INR 577.95
(2.37%)
INR 577.95
(2.37%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 2.02 Billion | 2.63 Billion | -1.03 Million | - | -186.75 Thousand |
| Net Income | 2.16 Billion | 2.6 Billion | -771.37 Thousand | -45.96 Thousand | -186.75 Thousand |
| Depreciation & Amortization | 732.4 Million | 625.4 Million | 421.18 Million | - | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 2.28 Million | - | - | - | - |
| Change in working capital | -1.21 Billion | -172.1 Million | -260.22 Thousand | 45.96 Thousand | - |
| Other non-cash items | 3.02 Billion | -431 Million | -421.18 Million | - | - |
| Investing Cash Flow | -2.17 Billion | -1.57 Billion | -1.38 Billion | - | - |
| Investments in PPE | -1.98 Billion | -1.19 Billion | -1.41 Billion | - | - |
| Acquisitions | - | - | 1.41 Billion | - | - |
| Investment purchases | -194 Million | -391.23 Million | -1.13 Million | - | - |
| Sales/Maturities of investments | 5.5 Million | - | 401 Thousand | - | - |
| Other Investing Activities | 5.4 Million | 9.73 Million | -1.38 Billion | - | - |
| Financing Cash Flow | 269.3 Million | -1.63 Billion | 2.72 Billion | - | 2.68 Million |
| Debt repayment | -499.9 Million | -1.24 Billion | -2.72 Billion | - | -186.75 Thousand |
| Dividends payments | -181.25 Million | -181.25 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -172.1 Million | -210.52 Million | 5.44 Billion | - | 2.5 Million |
| Accounts receivables | -1.25 Billion | -207.59 Million | -1.02 Billion | 46 Thousand | - |
| Accounts payables | 433.5 Million | 1.3 Billion | -718.62 Million | - | - |
| Inventory | -396.6 Million | -1.26 Billion | -559.92 Million | - | - |
| Other working capital | 433.48 Million | 70 Thousand | 2.3 Billion | 45.96 Thousand | - |
| Cash at beginning of period | 250.02 Million | 832.7 Million | 2.5 Million | 2.5 Million | - |
| Cash at end of period | 240.6 Million | 250 Million | 1.46 Million | 2.5 Million | 2.5 Million |
| Capital Expenditure | -1.98 Billion | -1.19 Billion | -1.41 Billion | - | - |
| Effect of forex changes on cash | - | 100 Thousand | -1.33 Billion | - | - |
| Net cash flow / Change in cash | -9.42 Million | -582.7 Million | -1.03 Million | - | 2.5 Million |
| Free Cash Flow | 34.3 Million | 1.43 Billion | -1.41 Billion | - | -186.75 Thousand |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 554.53 Million | 652.52 Million | 2.16 Billion | 527.6 Million | 518 Million | 470.9 Million |
| Depreciation & Amortization | - | - | 732.4 Million | 187.7 Million | 181.4 Million | 172 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 2.28 Million | 2.28 Million | - | - | - |
| Change in working capital | - | - | -1.21 Billion | - | - | - |
| Other non-cash items | -554.53 Million | -654.8 Million | 3.02 Billion | -527.6 Million | -518 Million | -470.9 Million |
| Investing Cash Flow | - | - | -2.17 Billion | - | - | - |
| Investments in PPE | - | - | -1.98 Billion | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -194 Million | - | - | - |
| Sales/Maturities of investments | - | - | 5.5 Million | - | - | - |
| Other Investing Activities | - | - | 5.4 Million | - | - | - |
| Financing Cash Flow | - | - | 269.3 Million | - | - | - |
| Debt repayment | - | - | -499.9 Million | - | - | - |
| Dividends payments | - | - | -181.25 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -172.1 Million | - | - | - |
| Accounts receivables | - | - | -1.25 Billion | - | - | - |
| Accounts payables | - | - | 433.5 Million | - | - | - |
| Inventory | - | - | -396.6 Million | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | 250.02 Million | 246.1 Million | -116.7 Million | 121.21 Million |
| Cash at end of period | - | - | 240.6 Million | 621.5 Million | 246.1 Million | 594.02 Million |
| Capital Expenditure | - | - | -1.98 Billion | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -9.42 Million | 375.4 Million | 362.8 Million | 472.8 Million |
| Free Cash Flow | - | - | 34.3 Million | 375.4 Million | 362.8 Million | 344 Million |
SELAN
UNH
002162
000738
ULTP
GULFNAV